NCT05222997

Brief Summary

People with the disease age-related macular degeneration (AMD) are treated with the Medical Eye Trainer (MET) system to improve their vision. The training is carried out over 2 months.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 8, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
25 days until next milestone

Study Start

First participant enrolled

February 28, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

August 18, 2022

Status Verified

August 1, 2022

Enrollment Period

10 months

First QC Date

January 8, 2022

Last Update Submit

August 16, 2022

Conditions

Age-Related Macular Degeneration

Keywords

Age-related macular degenerationAMDMedical Eye Trainer

Outcome Measures

Primary Outcomes (1)

  • Change in visual acuity

    2 months

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All persons with dry AMD who have no risk of reacting to the intense visual stimulus with a seizure. Existing double images are intensified by the increased visual acuity. All other affected persons can participate in the training.

You may qualify if:

  • Age-related macular degeneration

You may not qualify if:

  • Epilepsy
  • Double vision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BHS Ried

Ried im Innkreis, Upperaustria, A - 4910, Austria

RECRUITING

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Ophthalmology

Study Record Dates

First Submitted

January 8, 2022

First Posted

February 3, 2022

Study Start

February 28, 2022

Primary Completion

December 31, 2022

Study Completion

April 30, 2023

Last Updated

August 18, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Based on the European Data Protection Regulation, no data transfer is allowed.

Locations

AU(1)